{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:19:02Z","timestamp":1788844742381,"version":"build-2803163510"},"reference-count":156,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.pbb.2004.12.006","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T13:49:19Z","timestamp":1105624159000},"page":"351-362","source":"Crossref","is-referenced-by-count":38,"title":["Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats"],"prefix":"10.1016","volume":"80","author":[{"given":"Keita","family":"Ishiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Felsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2004.12.006_bib1","series-title":"Principles of neurology","first-page":"50","article-title":"Tremors, myoclonus, spasms and tics","author":"Adams","year":"1981"},{"key":"10.1016\/j.pbb.2004.12.006_bib2","first-page":"5","article-title":"Tremographic studies in tardive dyskinesia","volume":"12","author":"Alpert","year":"1976","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pbb.2004.12.006_bib3","doi-asserted-by":"crossref","first-page":"s41","DOI":"10.1007\/BF00442558","article-title":"Effect of neuroleptics on positive and negative symptoms and the deficit state","volume":"99","author":"Angst","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib4","series-title":"Tardive dyskinesia\u2014a task force report of the American Psychiatric Association","author":"APA Task Force on Tardive Dyskinesia","year":"1992"},{"key":"10.1016\/j.pbb.2004.12.006_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0091-3057(93)90203-6","article-title":"Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine","volume":"46","author":"Baskin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0091-3057(94)90446-4","article-title":"Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding","volume":"49","author":"Baskin","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00210842","article-title":"Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats","volume":"92","author":"Beninger","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1212\/WNL.40.7.1151","article-title":"Clozapine in idiopathic Parkinson's disease","volume":"40","author":"Bernardi","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2004.12.006_bib9","unstructured":"Betz A, Felsted J, Weber S, Salamone JD. The muscarinic M4 antagonist tropicamide reverses the locomotor suppression and tremulous jaw movements induced by pilocarpine in rats: possible relevance to parkinsonism. Program No. 308.6. 2004 Abstract Viewer\/Itinerary Planner. Washington (DC): Society for Neuroscience; 2004."},{"key":"10.1016\/j.pbb.2004.12.006_bib10","doi-asserted-by":"crossref","unstructured":"Betz A, Ishiwari K, Wisniecki A, Huyn N, Salamone JD. Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats. Psychopharmacology. [in press]","DOI":"10.1007\/s00213-004-2046-9"},{"key":"10.1016\/j.pbb.2004.12.006_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/070674379403900203","article-title":"Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms","volume":"39","author":"Bezchlibnyk-Butler","year":"1994","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4088\/JCP.v62n0111","article-title":"Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study","volume":"62","author":"Bruggeman","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000117742","article-title":"Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism","volume":"6","author":"Burnett","year":"1980","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2004.12.006_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-002-1247-3","article-title":"Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor","volume":"165","author":"Carlson","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4088\/JCP.v64n0807","article-title":"An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine","volume":"64","author":"Carlson","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0091-3057(97)98986-3","article-title":"Motor dysfunction produced by tacrine administration in rats","volume":"58","author":"Carriero","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib17","doi-asserted-by":"crossref","first-page":"s47","DOI":"10.1007\/BF00442559","article-title":"Clozapine: neuroleptic-induced EPS and tardive dyskinesia","volume":"99","author":"Casey","year":"1989","journal-title":"Psychopharmacology"},{"issue":"Suppl. 10","key":"10.1016\/j.pbb.2004.12.006_bib18","first-page":"55","article-title":"The relationship of pharmacology to side effects","volume":"58","author":"Casey","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 9","key":"10.1016\/j.pbb.2004.12.006_bib19","first-page":"25","article-title":"Pathophysiology of antipsychotic drug-induced movement disorders","volume":"65","author":"Casey","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0091-3057(95)02280-5","article-title":"Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements","volume":"54","author":"Chesler","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00430747","article-title":"Pimozide in the treatment of newly admitted schizophrenic patients","volume":"76","author":"Chouinard","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0022-510X(75)90165-3","article-title":"Tardive dyskinesia treated with pimozide","volume":"24","author":"Claveria","year":"1975","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pbb.2004.12.006_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02244890","article-title":"Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat","volume":"112","author":"Collins","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(03)00178-5","article-title":"The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism","volume":"148","author":"Correa","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.12.006_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0031-9384(98)00021-3","article-title":"Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements","volume":"64","author":"Cousins","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(97)00008-3","article-title":"Tremulous jawmovements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs","volume":"322","author":"Cousins","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.pbb.2004.12.006_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0014-2999(92)90400-X","article-title":"Haloperidol-induced vacuous chewing in rats: suppression by alpha-methyl-tyrosine","volume":"211","author":"Diana","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/schbul\/21.4.567","article-title":"Conventional antipsychotic medications for schizophrenia","volume":"21","author":"Dixon","year":"1995","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pbb.2004.12.006_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00008877-199902000-00010","article-title":"Haloperidol-induced within-session response decrement patterns and catalepsy in rats: Behavioural dissociation","volume":"10","author":"Drinkenburg","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archneur.1967.00470260014002","article-title":"Cholinergic-anticholinergic antagonism in parkinsonism","volume":"17","author":"Duvoisin","year":"1967","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pbb.2004.12.006_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02245101","article-title":"Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose","volume":"117","author":"Egan","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0091-3057(95)02041-1","article-title":"Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements","volume":"53","author":"Egan","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002130050095","article-title":"Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol","volume":"127","author":"Egan","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/BF00441962","article-title":"Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia","volume":"98","author":"Ellison","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(77)90325-9","article-title":"Tolerance of haloperidol catalepsy","volume":"41","author":"Ezrin-Waters","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mds.870120403","article-title":"The emerging role of clozapine in the treatment of movement disorders","volume":"12","author":"Factor","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2004.12.006_bib38","first-page":"135","article-title":"Cholinergic suppression of tardive dyskinesia","volume":"42","author":"Fahn","year":"1974","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00735871","article-title":"An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET","volume":"94","author":"Farde","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib40","doi-asserted-by":"crossref","first-page":"s28","DOI":"10.1007\/BF00442555","article-title":"D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics","volume":"99","author":"Farde","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib42","first-page":"235","article-title":"Pimozide treatment of the negative schizophrenic syndrome: an open trial","volume":"49","author":"Feinberg","year":"1988","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0091-3057(96)00385-1","article-title":"Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions","volume":"57","author":"Finn","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib44","first-page":"233","article-title":"Treatment of parkinsonian tremor with clozapine","volume":"2","author":"Fisher","year":"1990","journal-title":"J. Neurotrans."},{"key":"10.1016\/j.pbb.2004.12.006_bib45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0091-3057(86)90150-4","article-title":"Effects of pimozide on emitted force, duration and rate of operant response maintained at low and high levels of required force","volume":"25","author":"Fowler","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib46","first-page":"417","article-title":"Expression and pharmacological characterization of the human D3 dopamine receptor","volume":"268","author":"Freedman","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.12.006_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.870050307","article-title":"Clozapine-responsive tremor in Parkinson's disease","volume":"5","author":"Friedman","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2004.12.006_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0091-3057(92)90102-L","article-title":"Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice","volume":"41","author":"Fujiwara","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib49","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"32","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.pbb.2004.12.006_bib50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0447.1988.tb05138.x","article-title":"Tardive dyskinesia","volume":"77","author":"Gerlach","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pbb.2004.12.006_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00426516","article-title":"Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia","volume":"69","author":"Glassman","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF02245692","article-title":"Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function","volume":"113","author":"Glenthoj","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0014-2999(89)90486-X","article-title":"Intermittent neuroleptic treatment induces long-lasting abnormal mouthing in the rat","volume":"164","author":"Glenthoj","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(90)94191-Y","article-title":"Intermittent versus continuous neuroleptic treatment in a rat model","volume":"190","author":"Glenthoj","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00431935","article-title":"Oral dyskinesia in rats following brain lesions and neuroleptic drug administration","volume":"77","author":"Gunne","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib56","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0091-3057(86)90404-1","article-title":"Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration","volume":"25","author":"Gunne","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1227\/00006123-198410000-00007","article-title":"Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease","volume":"15","author":"Harbaugh","year":"1984","journal-title":"Neurosurgery"},{"key":"10.1016\/j.pbb.2004.12.006_bib58","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1007\/BF00442551","article-title":"The history of clozapine","volume":"99","author":"Hippus","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","article-title":"Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability","volume":"120","author":"Hoffman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib60","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02245832","article-title":"Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate","volume":"118","author":"Hyde","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib61","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1523\/JNEUROSCI.11-12-03822.1991","article-title":"Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to Parkinsonian symptoms","volume":"11","author":"Jicha","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2004.12.006_bib62","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2165\/00003495-200161150-00005","article-title":"Pharmacological options for the treatment of Tourette's disorder","volume":"61","author":"Jimenez-Jimenez","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2004.12.006_bib63","first-page":"1017","article-title":"Dose-dependent increases in rat spontaneous chewing rates during long-term administration of haloperidol but not clozapine","volume":"22","author":"Johansson","year":"1986","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pbb.2004.12.006_bib64","first-page":"CD003082","article-title":"Haloperidol versus placebo for schizophrenia","volume":"2","author":"Joy","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pbb.2004.12.006_bib65","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","article-title":"Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient","volume":"50","author":"Kapur","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib67","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(96)00451-7","article-title":"Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain","volume":"313","author":"Karolewicz","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib69","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF00589906","article-title":"Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity","volume":"99","author":"Kelley","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib70","series-title":"Design and analysis: a researchers handbook","author":"Keppel","year":"1982"},{"key":"10.1016\/j.pbb.2004.12.006_bib71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","article-title":"Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials","volume":"35","author":"Leucht","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pbb.2004.12.006_bib72","series-title":"Neurotransmitter receptors in actions of antipsychotic medications","first-page":"17","article-title":"General overview of contemporary antipsychotic medications","author":"Lidlow","year":"2000"},{"key":"10.1016\/j.pbb.2004.12.006_bib73","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1460-9568.2002.01944.x","article-title":"Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to \u2018early onset\u2019 vacuous chewing","volume":"15","author":"Marchese","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2004.12.006_bib74","series-title":"Psychiatric aspects of neurological disease","first-page":"219","article-title":"Spontaneous and drug-induced movement disorders in psychotic patients","author":"Marsden","year":"1975"},{"key":"10.1016\/j.pbb.2004.12.006_bib75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-3057(96)00225-0","article-title":"Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects","volume":"56","author":"Mayorga","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(98)00811-5","article-title":"Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats","volume":"364","author":"Mayorga","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib77","doi-asserted-by":"crossref","first-page":"s18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib79","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/248596a0","article-title":"Anti-muscarinic properties of neuroleptics and drug-induced parkinsonism","volume":"248","author":"Miller","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2004.12.006_bib80","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02439593","article-title":"Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities","volume":"93","author":"Mithani","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib81","first-page":"492","article-title":"Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics","volume":"43","author":"Moleman","year":"1982","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib82","first-page":"545","article-title":"The behavioral pharmacology of olanzapine, a novel \u201catypical\u201d antipsychotic agent","volume":"262","author":"Moore","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 10","key":"10.1016\/j.pbb.2004.12.006_bib83","first-page":"37","article-title":"Behavioral pharmacology of olanzapine: a novel antipsychotic drug","volume":"58","author":"Moore","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib84","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1176\/ajp.152.10.1444","article-title":"D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients","volume":"152","author":"Nordstrom","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib85","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archpsyc.55.3.283","article-title":"Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients","volume":"55","author":"Nordstrom","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib86","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00431469","article-title":"Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism","volume":"84","author":"Noring","year":"1984","journal-title":"Psychopharmacology"},{"issue":"Suppl. B","key":"10.1016\/j.pbb.2004.12.006_bib87","first-page":"43","article-title":"Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity","volume":"55","author":"Olney","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib88","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.npp.1380292","article-title":"NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia","volume":"13","author":"Olney","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0404.1986.tb03279.x","article-title":"Clozapine in the treatment of tremor","volume":"73","author":"Pakkenberg","year":"1986","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.pbb.2004.12.006_bib91","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0091-3057(88)90383-8","article-title":"Assessment of pimozide's motor and hedonic effects on operant behavior in rats","volume":"31","author":"Porter","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2004.12.006_bib93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-4328(01)00168-1","article-title":"Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease","volume":"122","author":"Rodriguez Diaz","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.12.006_bib94","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02311185","article-title":"D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs","volume":"120","author":"Roth","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib95","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00427817","article-title":"Cholinergic modulation of perioral behavior induced by chronic neuroleptic administration to rats","volume":"79","author":"Rupniak","year":"1983","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00427326","article-title":"Pharmacological characterization of spontaneous or drug-induced purposeless chewing movements in rats","volume":"85","author":"Rupniak","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib97","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00178501","article-title":"Acute dystonia induced by neuroleptic drugs","volume":"88","author":"Rupniak","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s002130000570","article-title":"Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats","volume":"153","author":"Sakai","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib99","series-title":"Handbook of psychopharmacology","first-page":"575","article-title":"The actions of neuroleptic drugs on appetitive instrumental behaviors","author":"Salamone","year":"1987"},{"key":"10.1016\/j.pbb.2004.12.006_bib100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF02245133","article-title":"Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes","volume":"107","author":"Salamone","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(95)00164-6","article-title":"Vacuous jaw movements induced by reserpine and low-dose apomorphine: possible model of parkinsonian tremor","volume":"53","author":"Salamone","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib102","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00178508","article-title":"Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat","volume":"88","author":"Salamone","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib103","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF02247136","article-title":"Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat","volume":"102","author":"Salamone","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib104","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02245659","article-title":"Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure","volume":"104","author":"Salamone","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02249408","article-title":"Different behavioral effects of haloperidol, clozapine and thioridazine in an instrumental lever pressing\/feeding procedure","volume":"125","author":"Salamone","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib106","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0301-0082(98)00053-7","article-title":"Tremulous jaw movements in rats: a model of parkinsonian tremor","volume":"56","author":"Salamone","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2004.12.006_bib107","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/S0024-3205(01)01055-4","article-title":"Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism","volume":"68","author":"Salamone","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2004.12.006_bib108","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbr.2004.05.019","article-title":"Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243","volume":"156","author":"Salamone","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.12.006_bib109","first-page":"708","article-title":"Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats","volume":"272","author":"Sanger","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.12.006_bib110","first-page":"95","article-title":"Drug holidays alter onset of oral movements in rats following chronic haloperidol","volume":"19","author":"Sant","year":"1984","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib112","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(90)90077-J","article-title":"Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia","volume":"181","author":"See","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib113","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF02244615","article-title":"Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats","volume":"100","author":"See","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib114","first-page":"261","article-title":"Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4","volume":"7","author":"Seeman","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib116","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.pbb.2004.12.006_bib117","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2004.12.006_bib118","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0893-133X(96)00187-X","article-title":"Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors","volume":"16","author":"Seeman","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib119","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1542\/peds.79.6.1032","article-title":"Pimozide treatment of tic and Tourette disorders","volume":"79","author":"Shapiro","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.pbb.2004.12.006_bib120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.184.4143.1243","article-title":"Drugs, neurotransmitters and schizophrenia","volume":"184","author":"Snyder","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.pbb.2004.12.006_bib121","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/S0024-3205(01)01315-7","article-title":"Effects of dopaminergic and cholinergic interactions on rat behavior","volume":"69","author":"Sousa","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2004.12.006_bib122","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0031-9384(86)90315-X","article-title":"Effects of pimozide on appetitive behavior and locomotor activity: dissimilarity of effects when compared to extinction","volume":"36","author":"Spivak","year":"1986","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib123","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s002130050363","article-title":"Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness","volume":"132","author":"Stanford","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0091-3057(93)90371-Y","article-title":"The effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats","volume":"46","author":"Steinpreis","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02257414","article-title":"Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine","volume":"111","author":"Steinpreis","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib126","first-page":"129","article-title":"The effects of cyproheptadine on vacuous jaw movements in rats: a comparison with haloperidol and clozapine","volume":"32","author":"Steinpreis","year":"1996","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pbb.2004.12.006_bib127","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0166-4328(96)02262-0","article-title":"Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats","volume":"86","author":"Steinpreis","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.12.006_bib128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050652","article-title":"The effects of the atypical antipsychotic amperozide on vacuous jaw movements in rats: a novel dose response profile","volume":"138","author":"Steinpreis","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(87)90671-6","article-title":"Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT","volume":"142","author":"Stewart","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00442255","article-title":"The pharmacological characterization of pilocarpine-induced chewing in the rat","volume":"97","author":"Stewart","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib131","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF00451690","article-title":"Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists","volume":"98","author":"Stoessl","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib132","first-page":"CD001949","article-title":"Pimozide for schizophrenia and related psychoses","volume":"3","author":"Sultana","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2004.12.006_bib133","doi-asserted-by":"crossref","first-page":"11s","DOI":"10.1097\/00004714-199502001-00003","article-title":"Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism","volume":"15","author":"Svensson","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib134","first-page":"s9","article-title":"Neuroleptic-induced extrapyramidal reactions: classification, description and diagnosis","volume":"6","author":"Tarsy","year":"1983","journal-title":"Clin. Neuro-psychopharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00023210-200216010-00003","article-title":"Effects of newer antipsychotics on extrapyramidal function","volume":"16","author":"Tarsy","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2004.12.006_bib136","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/jnnp.38.4.331","article-title":"Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias","volume":"38","author":"Tarsy","year":"1975","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib137","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.v58n0505","article-title":"Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia","volume":"58","author":"Tran","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib138","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002130050322","article-title":"Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function","volume":"132","author":"Trevitt","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib139","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002130050593","article-title":"Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function","volume":"137","author":"Trevitt","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002130051063","article-title":"Behavioral assessment of atypical antipsychotics in rats: studies of the effects of olanzapine (Zyprexa)","volume":"145","author":"Trevitt","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib141","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00007611-199303000-00019","article-title":"Clinical use of pimozide","volume":"86","author":"Tueth","year":"1993","journal-title":"South. Med. J."},{"key":"10.1016\/j.pbb.2004.12.006_bib142","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2004.12.006_bib143","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1300233","article-title":"Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats","volume":"28","author":"Turrone","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib144","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000118403","article-title":"Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent?","volume":"18","author":"van Kammen","year":"1987","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2004.12.006_bib145","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2004.12.006_bib146","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib147","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00690944","article-title":"The status of late-onset vacuous chewing\/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?","volume":"91","author":"Waddington","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib148","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0893-133X(01)00261-5","article-title":"Dopamine D2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects","volume":"25","author":"Wadenberg","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib149","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1176\/ajp.137.5.627","article-title":"Physostigmine test in the rabbit syndrome and tardive dyskinesia","volume":"137","author":"Weiss","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0091-3057(94)90524-X","article-title":"Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing","volume":"48","author":"Wiley","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.12.006_bib151","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-2999(98)00312-4","article-title":"Dopamine D2 and D4 receptor ligands: relation to antipsychotic action","volume":"351","author":"Wilson","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib152","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-198912000-00004","article-title":"Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism","volume":"9","author":"Wirshing","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2004.12.006_bib153","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1176\/jnp.3.1.10","article-title":"Electromechanical characteristics of tardive dyskinesia","volume":"3","author":"Wirshing","year":"1991","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2004.12.006_bib154","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00213-003-1521-z","article-title":"Motor effects of GABAA antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats","volume":"170","author":"Wisniecki","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.12.006_bib155","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.pnpbp.2003.09.005","article-title":"The dopamine D4 receptors and mechanisms of antipsychotic atypicality","volume":"27","author":"Wong","year":"2003","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2004.12.006_bib156","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pnpbp.2003.10.006","article-title":"Adverse effects of risperidone and haloperidol treatment in schizophrenia","volume":"28","author":"Yen","year":"2004","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704003958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704003958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T15:06:44Z","timestamp":1682953604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305704003958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":156,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0091305704003958"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2004.12.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}